CompletedPhase 2NCT01168440
Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease
Studying Von Hippel-Lindau disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
- Principal Investigator
- Stephane RICHARD, MD, PhDHôpital Kremlin-Bicêtre (France)
- Intervention
- Sunitinib(drug)
- Enrollment
- 5 enrolled
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2010 – 2011
Study locations (3)
- Hospital Saint André - Service de cancérologie, Bordeaux, France
- Hopital Kremlin-Bicêtre, Le Kremlin-Bicêtre, France
- Hôpital Européen Georges Pompidou - Service d'Oncologie Médicale, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01168440 on ClinicalTrials.govOther trials for Von Hippel-Lindau disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07405164Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)Merck Sharp & Dohme LLC
- RECRUITINGPHASE2NCT07171905CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau DiseaseIRCCS Ospedale San Raffaele
- ENROLLING BY INVITATIONNANCT05737602Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau DiseaseMassachusetts General Hospital
- RECRUITINGPHASE2NCT07167329Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL TrialJosé Claudio Casali da Rocha
- RECRUITINGNCT05955014Data Collection Protocol for Patients With Von Hippel Lindau DiseaseM.D. Anderson Cancer Center
- RECRUITINGNCT06194669Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule CellsIRCCS San Raffaele
- RECRUITINGNANCT05424016Propranolol and Von Hippel-Lindau DiseaseAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE2NCT04924075Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)Merck Sharp & Dohme LLC